Trinity Biotech (TRIB) Short-Term Debt issuances (2022 - 2023)
Trinity Biotech's (TRIB) quarterly Short-Term Debt issuances came in at -$10.0 million in Q2 2023, up 70.87% year-over-year from -$5.9 million in Q2 2022, and up 70.87% quarter-over-quarter from -$34.5 million in Q2 2022.
Powered by 
Analysis
Trinity Biotech (TRIB) Short-Term Debt issuances (2022 - 2023) Analysis & Trends
Trinity Biotech has disclosed Short-Term Debt issuances across 2 years of filings, most recently posting -$10.0 million for Q2 2023.
- In Q2 2023, Short-Term Debt issuances rose 70.87% year-over-year to -$10.0 million; the TTM figure through Dec 2023 stood at -$10.0 million (changed N/A YoY), while the FY2023 annual figure was -$10.0 million, up 70.87% from the prior year.
- Short-Term Debt issuances came in at -$10.0 million for Q2 2023 at Trinity Biotech, up from -$34.5 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of -$10.0 million in Q2 2023 to a low of -$34.5 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.65 Bn | 27.55 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.10 Bn | 3.72 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | - |
| 6 | Ceribell | 924.94 Mn | 795.68 Mn | 25.94 Mn | - |
| 7 | QuidelOrtho | 874.24 Mn | 750.84 Mn | - | 120.00 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 19.20 Mn |
| 9 | Prenetics Global | 341.11 Mn | 282.06 Mn | 30.20 Mn | - |
| 10 | Trinity Biotech | 5.47 Mn | 5.47 Mn | - | - |